SANGAMO THERAPEUTICS, INC (SGMO) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2011: $7.20M2012: $17.64M2013: $19.13M2014: $36.58M2015: $24.80M2016: $21.70M2017: $98.84M2018: $223.14M2019: $204.78M2020: $441.18M2021: $346.58M2022: $267.55M2023: $82.43M2024: $78.86M2025: $74.01M$74.01M
2011Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$74.01M-6.2%
2024$78.86M-4.3%
2023$82.43M-69.2%
2022$267.55M-22.8%
2021$346.58M-21.4%
2020$441.18M+115.4%
2019$204.78M-8.2%
2018$223.14M+125.8%
2017$98.84M+355.6%
2016$21.70M-12.5%
2015$24.80M-32.2%
2014$36.58M+91.2%
2013$19.13M+8.5%
2012$17.64M+144.8%
2011$7.20M